Arteriosclerosis (Disease Or Phenotype)

Omim:MTHU037126

Nci:C34398

Msh:D001161

Mondo:MONDO:2277

Medcin:MEDCIN:353823

Mdr:MDR:10003210

Id:5ee698ad-7e8e-50ad-96ad-2a8c390e8282

Icpc2icd10eng:MTHU008058

Icd10cm:I70

Efo:EFO:9086

Doid:DOID:2349

Chv:CHV:1458

Results found

Linked to

	Label	Description
	(E)-(3R,5S)-7-[4-(4-Fluoro-phenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid anion indication Arteriosclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	monacolin K indication Arteriosclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	atorvastatin indication Arteriosclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Fluvastatin sodium indication Arteriosclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	simvastatin indication Arteriosclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Cemdisiran indication Arteriosclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Pravastatin indication Arteriosclerosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

(E)-(3R,5S)-7-[4-(4-Fluoro-phenyl)-6-isopropyl-2-(methanesulfonyl-methyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid anion indication Arteriosclerosis

Knowledge Graph Assertion (Entity type)